Phase 2 Safety trials recruiting now

All Safety trials, every phase

Phase 2 Safety trials

• Efficacy and Safety of AK104 Combined With Chemotherapy and Cetuximab or Bevacizumab
  NCT07253896 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT
  NCT07037680 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
  NCT07461220 · Phase: Phase 1, Phase 2 · Ages: 50 Years to 90 Years · Sex: All (male and female) · 14 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.